TABLE 2.
Univariate analysis of prognostic factors in 76 patients with gastric cancer.
| Characteristics | All cases | 5-year survival rate | X2 | p-Value |
| Gender | ||||
| Male | 46 | 54.35% (25/46) | 0.039 | 0.842 |
| Female | 30 | 56.67% (17/30) | ||
| Age (years) | ||||
| <60 | 35 | 54.29% (19/35) | 0.025 | 0.874 |
| ≥60 | 41 | 56.10% (23/41) | ||
| Tumor size (cm) | ||||
| ≤4.8 | 48 | 66.67% (32/48) | 6.853 | 0.009 |
| >4.8 | 28 | 35.71% (10/28) | ||
| Lauren classification | ||||
| Intestinal | 21 | 76.19% (16/21) | 8.143 | 0.017 |
| Diffuse | 30 | 36.67% (11/30) | ||
| Mixed | 25 | 60.00% (15/25) | ||
| Tissue differentiation | ||||
| Well | 5 | 100.00% (5/5) | 6.521 | 0.037 |
| Moderate | 36 | 61.11% (22/36) | ||
| Poor | 35 | 42.86% (15/35) | ||
| Infiltrating depth | ||||
| T1 | 3 | 100.00% (3/3) | 9.041 | 0.019 |
| T2 | 26 | 69.23% (18/26) | ||
| T3 | 40 | 50.00% (20/40) | ||
| T4 | 7 | 14.29% (1/7) | ||
| Nodal status | ||||
| N0 | 18 | 72.22% (13/18) | 3.208 | 0.361 |
| N1 | 16 | 50.00% (8/16) | ||
| N2 | 18 | 44.44% (8/18) | ||
| N3 | 25 | 52.00% (13/25) | ||
| Distant metastasis | ||||
| M0 | 74 | 56.76% (42/74) | 2.537 | 0.197 |
| M1 | 2 | 0.00% (0/2) | ||
| TNM stage | ||||
| I | 6 | 83.33% (5/6) | 7.253 | 0.041 |
| II | 28 | 67.86% (19/28) | ||
| III | 40 | 45.00% (18/40) | ||
| IV | 2 | 0.00% (0/2) | ||
| ASNR expression | ||||
| Low | 36 | 75.00% (27/36) | 10.777 | 0.001 |
| High | 40 | 37.50% (15/40) | ||